Why Should the FDA Focus on Pragmatic Clinical Research?
Publication
, Other
Abbasi, AB; Curtis, LH; Califf, RM
Published in: JAMA
July 9, 2024
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
July 9, 2024
Volume
332
Issue
2
Start / End Page
103 / 104
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Pragmatic Clinical Trials as Topic
- Humans
- General & Internal Medicine
- Drug Approval
- Chronic Disease
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Abbasi, A. B., Curtis, L. H., & Califf, R. M. (2024). Why Should the FDA Focus on Pragmatic Clinical Research? JAMA. United States. https://doi.org/10.1001/jama.2024.6227
Abbasi, Ali B., Lesley H. Curtis, and Robert M. Califf. “Why Should the FDA Focus on Pragmatic Clinical Research?” JAMA, July 9, 2024. https://doi.org/10.1001/jama.2024.6227.
Abbasi AB, Curtis LH, Califf RM. Why Should the FDA Focus on Pragmatic Clinical Research? Vol. 332, JAMA. 2024. p. 103–4.
Abbasi, Ali B., et al. “Why Should the FDA Focus on Pragmatic Clinical Research?” JAMA, vol. 332, no. 2, 9 July 2024, pp. 103–04. Pubmed, doi:10.1001/jama.2024.6227.
Abbasi AB, Curtis LH, Califf RM. Why Should the FDA Focus on Pragmatic Clinical Research? JAMA. 2024. p. 103–104.
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
July 9, 2024
Volume
332
Issue
2
Start / End Page
103 / 104
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Pragmatic Clinical Trials as Topic
- Humans
- General & Internal Medicine
- Drug Approval
- Chronic Disease
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences